Stephen Nicolle Joins Appili Board
Appili Therapeutics Inc., a Halifax-based anti-infective drug development company, today named former STI Technologies CEO Stephen Nicolle to its board of directors.
A seasoned executive, Nicolle has led Canadian and American companies to deliver innovative customer value and returned over $100 million to their investors. In Halifax, he is known for leading the healthcare IT company STI in its